Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) -Positive Breast Cancer After Prior HER2-Directed Therapy

✍ Scribed by Burris, H. A.; Rugo, H. S.; Vukelja, S. J.; Vogel, C. L.; Borson, R. A.; Limentani, S.; Tan-Chiu, E.; Krop, I. E.; Michaelson, R. A.; Girish, S.; Amler, L.; Zheng, M.; Chu, Y.-W.; Klencke, B.; O'Shaughnessy, J. A.

• Book ID: 119974800
• Publisher: American Society of Clinical Oncology
• Year: 2011
• Tongue: English
• Weight: 176 KB
• Volume: 29
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2010.29.5865